Finasteride Tablet, Film Coated
Product Images NDC 71335-1898

7 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 71335-1898). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structutre (Finasteride Structure)

Structutre (Finasteride Structure)
Chemical structure diagram of the active ingredient Finasteride used in the medication Finasteride 5 mg film-coated tablets by Bryant Ranch Prepack.*
FDA Label Image

Finasteride-fig.1 (Finasteride Fig.1)

Finasteride-fig.1 (Finasteride Fig.1)
A line graph showing mean change from baseline over 4 years comparing Finasteride and placebo. The y-axis measures mean change from baseline ± 1 SE, spanning 0 to -6, and the x-axis shows time points from baseline through year 4. Data points indicate a greater mean change reduction for Finasteride than placebo throughout the period. Sample sizes for each group at each time point are noted below the x-axis.*
FDA Label Image

Finasteride-fig.2 (Finasteride Fig.2)

Finasteride-fig.2 (Finasteride Fig.2)
A line graph comparing the percent of patients over 48 months in two groups: Finasteride and Placebo. The y-axis represents the percent of patients up to 15%, and the x-axis shows observation time in months from 0 to 48. The Finasteride group has a lower cumulative percentage compared to the Placebo group. Below the graph are tables listing cumulative event numbers and patients at risk per year for both groups.*
FDA Label Image

Finasteride-fig.3 (Finasteride Fig.3)

Finasteride-fig.3 (Finasteride Fig.3)
A line graph showing mean percent change from baseline over four years for Finasteride 5 mg and placebo groups. The vertical axis represents mean percent change with error bars (±1 SE), and the horizontal axis indicates time points from baseline to year 4. Finasteride data points decrease below baseline, while placebo data points increase above baseline over time. Sample sizes are listed below each time point for both groups.*
FDA Label Image

Finasteride-fig4a (Finasteride Fig4a)

Finasteride-fig4a (Finasteride Fig4a)
A line graph showing mean percent change from baseline over four years for two groups: placebo and finasteride. The x-axis represents time from baseline to year 4, while the y-axis shows mean percent change from baseline with a range from -20 to 20. The placebo group shows an increasing positive change, whereas the finasteride group shows a decreasing negative change. Sample sizes for each group at different time points are also indicated.*
FDA Label Image

Finasteride-fig.5 (Finasteride Fig.5)

Finasteride-fig.5 (Finasteride Fig.5)
A line graph showing the percent of subjects with an event over 5.5 years from randomization. Four lines represent Placebo, Finasteride, Doxazosin, and Combination treatments, with Placebo having the highest event percentage and Combination the lowest over time.*
FDA Label Image

Label (Lbl713351898)

Label (Lbl713351898)
Finasteride 5 mg film-coated oral tablet label packed by Bryant Ranch Prepack, Burbank CA. The label compares the product to Proscar 5 mg tablet by Alkem Laboratories Limited. It shows storage instructions at 20°-25°C (68°-77°F) and includes lot number 1523487, a bar code, and NDC 7133518981. The package count is 100 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.